U.S. Banks Stock News

NasdaqGS:CVCO
NasdaqGS:CVCOConsumer Durables

Is Cavco Industries (CVCO)'s Design Recognition Hinting at a Deeper Competitive Edge in Affordable Housing?

Cavco Industries recently received two national design awards from the Manufactured Housing Institute at the 2026 MHI Congress & Expo in Las Vegas, recognizing excellence in both single-section manufactured and multi-section modular home design. This industry recognition underscores Cavco’s emphasis on design innovation and product quality as it works to broaden access to modern, affordable housing solutions. Next, we’ll explore how this recognition for design innovation may influence...
NYSE:GOLD
NYSE:GOLDRetail Distributors

Goldcom Expands Into Minting As Valuation And Growth Story Evolve

Gold.com (NYSE:GOLD) has acquired Sunshine Minting, Inc., expanding directly into minting and refining. The company has created a new Minting & Refining Division and appointed Jamie Meadows as its CEO. This move marks a shift in Gold.com's operational footprint beyond its existing business lines. For investors watching Gold.com at a share price of $44.51, this acquisition comes after substantial long term share price moves, including a 28.0% return year to date and a 202.8% return over five...
NYSE:FTV
NYSE:FTVMachinery

How Insider Selling and Aging Profit Engines At Fortive (FTV) Have Changed Its Investment Story

In recent days, Fortive has been in focus as investors reassess the company’s aging profit drivers, flat earnings per share over the past five years, and weaker returns on capital amid ongoing end‑market pressures. An interesting angle is how these operational challenges intersect with recent concerns that Fortive’s shares may be trading above intrinsic value while insiders have sold US$400,000 of stock without corresponding purchases. With investor attention on insider selling and business...
NYSE:DHR
NYSE:DHRLife Sciences

Assessing Danaher (DHR) Valuation After New Access MeMed BV Diagnostic Approval

Access MeMed BV approval puts Danaher’s diagnostics in focus Beckman Coulter Diagnostics, part of Danaher (DHR), has received CE 2797 mark approval under the IVDR for its Access MeMed BV assay, a rapid bacterial versus viral infection test delivering results in about 20 minutes. See our latest analysis for Danaher. Despite the positive Diagnostics news, Danaher’s share price has had mixed momentum, with a 6.0% 1 month share price return and a 16.5% 3 month decline, while the 1 year total...
NasdaqGS:PRGS
NasdaqGS:PRGSSoftware

Will Progress Software's (PRGS) Bengaluru AI Hub Expansion Recast Its Operational Scale and Innovation Narrative?

Progress Software recently relocated and expanded its Bengaluru office at Embassy Tech Village, reinforcing its India Global Capability Center focused on AI-led innovation across engineering, product development, sales, customer success, marketing and operations. This move also deepens the company’s integration into India’s technology ecosystem while broadening its customer-facing capabilities and community initiatives, including a partnership with The Bodhi Tree Foundation. Next, we’ll...
NYSE:VNT
NYSE:VNTElectronic

Is Vontier (VNT) Offering Value After A 24.7% One Year Share Price Gain

Wondering if Vontier at around US$37.59 is offering genuine value or just looks inexpensive on the surface? This article breaks down what the current price really implies. The stock has returned 6.4% over the last 7 days and 4.4% over the past month, while the 1 year return sits at 24.7% and the year to date move is around a 0.6% decline. Recent coverage has focused on Vontier's role as a technology player in the industrial and mobility space. This has kept investor attention on how its...
NasdaqGS:NDSN
NasdaqGS:NDSNMachinery

Is It Too Late To Consider Nordson (NDSN) After A 54% One-Year Rally?

If you are wondering whether Nordson's current share price lines up with its underlying worth or if expectations have run ahead of fundamentals, this article breaks down the numbers so you can judge the value story for yourself. Nordson's share price last closed at US$279.01, with returns of 5.1% over the past week, 4.3% over the last 30 days, 15.8% year to date and 54.5% over the past year. These moves in the share price sit against a backdrop of ongoing interest in industrial and capital...
NYSE:INFQ
NYSE:INFQTech

Infleqtion’s ISS Quantum Hardware Puts Focus On Sensing Revenue Potential

Infleqtion (NYSE:INFQ) has delivered upgraded quantum hardware to the International Space Station to support the Cold Atom Laboratory. The new hardware is intended to advance quantum sensing and navigation research in space. The company is also preparing a leadership event focused on unifying the global quantum technology ecosystem and accelerating commercial adoption. Infleqtion operates across quantum hardware, software, and related applications, and is positioning itself as a key...
NasdaqCM:KOPN
NasdaqCM:KOPNSemiconductor

Kopin (KOPN) Profitability Hinges On US$16.2m One Off Gain As Valuation Stays Rich

Kopin (KOPN) has wrapped up FY 2025 with fourth quarter revenue of about US$8.4 million and basic EPS of roughly US$0.04, supported by trailing 12 month EPS of about US$0.01 and net income of around US$2.5 million on revenue of roughly US$39.3 million. Over recent quarters the company has seen quarterly revenue range from about US$8.4 million to US$12.0 million, while basic EPS has moved from losses of roughly US$0.03 to a profit of about US$0.04. This trailing period includes a US$16.2...
NYSE:PCOR
NYSE:PCORSoftware

Is It Time To Reassess Procore Technologies (PCOR) After Its Recent Share Price Pullback

If you are wondering whether Procore Technologies at around US$49.60 is starting to look interesting, the key question is how that price compares with the value of the underlying business. The stock has recently pulled back, with returns of an 11.3% decline over 7 days, a 13.2% decline over 30 days, and a 29.2% decline year to date, contributing to an 18.2% decline over the past year. These moves come as Procore continues to attract attention as a construction software platform, with...
NYSE:FBK
NYSE:FBKBanks

FB Financial (FBK) Net Interest Margin Holds Near 3.9% Challenging Cost Concern Narratives

FB Financial (FBK) has put up a clean set of Q1 2026 numbers, with revenue of US$169.3 million and basic EPS of US$1.11, setting the tone against a trailing twelve month backdrop of US$557.7 million in revenue and EPS of US$2.76. Over recent quarters, revenue has moved from US$128.4 million in Q1 2025 to US$169.3 million in Q1 2026, while quarterly EPS has shifted from US$0.84 to US$1.11, giving you a clearer run rate to judge how sustainable current profitability and margins might be. See...
NasdaqGM:RENT
NasdaqGM:RENTSpecialty Retail

Rent The Runway (RENT) Q3 Profit Swing Challenges Balance Sheet Bear Narratives

Rent the Runway (RENT) just posted a sharp swing in its latest FY 2026 third quarter numbers, reporting revenue of US$87.6 million and basic EPS of US$13.69 on net income of US$76.5 million. Earlier quarters in the same fiscal year showed losses at both the EPS and net income line. Over recent periods, revenue has moved from US$75.9 million in Q3 2025 to US$76.4 million in Q4 2025, then to US$69.6 million in Q1 2026, US$80.9 million in Q2 2026 and now US$87.6 million. Basic EPS shifted from a...
NasdaqGS:VSNT
NasdaqGS:VSNTMedia

Versant Media Group Buy Of StockStory Aims To Deepen CNBC Tools

Versant Media Group (NasdaqGS:VSNT) has acquired AI-driven financial analysis platform StockStory. The deal brings StockStory’s digital investing tools and team into CNBC’s platforms. The acquisition is aimed at expanding Versant’s suite of tools for individual investors and financial professionals. Versant Media Group, the parent company behind several financial media properties including CNBC, is adding StockStory to deepen its technology-driven investing features. As more investors rely...
NasdaqGS:NFE
NasdaqGS:NFEOil and Gas

New Fortress Energy (NFE) Deep FY 2025 EPS Loss Tests Bullish LNG Growth Narrative

New Fortress Energy (NFE) closed out FY 2025 with Q4 revenue of US$415.9 million and a basic EPS loss of US$2.77, alongside a net income loss of US$788.4 million. Over the last six reported quarters, revenue has ranged from US$301.7 million to US$668.2 million, while basic EPS has swung between a small profit of US$0.03 and a loss of US$2.77. This gives investors a wide view of how top line scale and per share losses have moved together. With trailing 12 month revenue at about US$1.5 billion...
NasdaqGS:DYN
NasdaqGS:DYNBiotechs

Is It Too Late To Consider Dyne Therapeutics (DYN) After A 152% One‑Year Surge?

If you are wondering whether Dyne Therapeutics at around US$19.81 is still offering value or has already priced in much of the story, the next sections aim to put the current share price in context. The stock has recently posted returns of 9.1% over 7 days, 10.5% over 30 days, 7.1% year to date and 152.4% over the past year, which can change how investors see both its potential and its risks. Recent news flow around Dyne Therapeutics has centered on its progress as a biotechnology name and...
NasdaqCM:ASPI
NasdaqCM:ASPIChemicals

A Look At ASP Isotopes (ASPI) Valuation After Earnings Surge In Revenue And Losses

Why ASP Isotopes (ASPI) Is Drawing Attention After Its Latest Earnings ASP Isotopes (ASPI) is back on investors’ radar after its full year 2025 earnings report, which paired US$23.85 million of revenue with a net loss of US$175.09 million, along with a follow up business update call. See our latest analysis for ASP Isotopes. The share price now sits at US$5.00, with a 7 day share price return of 22.85% contrasting with a 90 day share price return decline of 29.48%. The 3 year total...
NasdaqGS:SBLK
NasdaqGS:SBLKShipping

Is It Too Late To Consider Star Bulk Carriers (SBLK) After Its 78.8% One Year Rally?

If you are wondering whether Star Bulk Carriers is priced attractively or already reflects its potential, this article breaks down what the current share price could mean for you as an investor. At a last close of US$24.73, the stock has returns of 2.6% over 7 days, 13.2% over 30 days, 27.7% year to date and 78.8% over 1 year. These recent moves are front of mind when thinking about value and risk. Recent coverage has focused on Star Bulk Carriers within the broader shipping sector,...
NYSE:ATEN
NYSE:ATENSoftware

Is A10’s AI Security Push Reshaping The Investment Case For A10 Networks (ATEN)?

A10 Networks has recently reported its fourth quarter and full year 2024 results, showing modest revenue growth and highlighting progress across both service provider and enterprise customers. The company is leaning into new security and AI-focused offerings, including bot protection, DDoS mitigation, and solutions tailored for GPU-based AI infrastructure, which management positions as key future growth drivers. We’ll now examine how these emerging AI and security product initiatives may...
NYSE:ENOV
NYSE:ENOVMedical Equipment

Is It Time To Reconsider Enovis (ENOV) After Recent Share Price Rebound

If you are wondering whether Enovis is priced attractively right now, the recent share performance and valuation checks offer some clear signals to unpack. The stock last closed at US$24.86, with returns of 9.2% over 7 days and 8.1% over 30 days, while year to date it is down 6.2%, and the 1 year return sits at a 23.1% decline, extending a 55.3% decline over 3 years and 67.8% over 5 years. These moves sit against a backdrop where investors have been reassessing Enovis within the Medical...
NYSE:SLGN
NYSE:SLGNPackaging

Has Silgan Holdings (SLGN) Share Price Weakness Opened Up A Valuation Opportunity?

Wondering whether Silgan Holdings at around US$41.87 is priced for opportunity or caution? This article breaks down what the current share price could be implying about value. The stock is up 6.1% over the last 7 days and 0.6% over the past month, yet year to date it is only up 1.5%, and the 1 year return sits at a 14.0% decline. That mix of recent gains and a weaker 1 year and 3 year record, with returns of a 14.0% decline and 16.2% decline respectively, has kept Silgan on the radar for...
NYSE:OII
NYSE:OIIEnergy Services

Is It Too Late To Consider Oceaneering International (OII) After A 120% One Year Rally?

Wondering if Oceaneering International at around US$37.43 is offering fair value or if the market is getting ahead of itself? This article walks you through the key signals that can help you answer that question. The stock has delivered returns of 2.3% over the last 7 days, 12.5% over 30 days, 50.6% year to date and 120.4% over the past year, with 3 year and 5 year returns of 105.8% and 245.6% respectively. This naturally raises questions about what is already priced in. Recent attention on...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Is It Too Late To Consider ImmunityBio (IBRX) After Its 261% Year To Date Surge?

Wondering if ImmunityBio at around US$7.30 is still priced for opportunity or already reflecting the story most investors see? This article is built to help you frame that question clearly. The stock has delivered a 261.4% return year to date and 162.6% over the past year. However, the last 30 days show a 13.0% decline and the last week a 6.4% gain, which can change how you think about both potential and risk. Recent coverage of ImmunityBio has focused on how its clinical pipeline and...
NYSE:AMTM
NYSE:AMTMProfessional Services

Amentum’s Artemis II Role Highlights Mission Critical Space And Defense Ambitions

Amentum Holdings (NYSE:AMTM) played an essential role in NASA's Artemis II mission, the first crewed launch of the Artemis program. The company supported ground systems operations, critical launch support, safety systems deployment, and post mission recovery of the Orion spacecraft. This work contributes to NASA's goal of a sustained lunar presence and future deep space missions. Amentum operates as a mission critical engineering and operations partner to US government agencies and other...